Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 12/20 | 0.74 |
| ▸ | HTR2C | P28335 | 8/20 | 0.60 |
| ▸ | HTR2B | P41595 | 7/20 | 0.59 |
| ▸ | HTR1A | P08908 | 3/20 | 0.59 |
| ▸ | DRD1 | P21728 | 1/20 | 0.59 |
| ▸ | HTR1D | P28221 | 1/20 | 0.59 |
| ▸ | HTR1B | P28222 | 1/20 | 0.59 |
| ▸ | HTR1E | P28566 | 1/20 | 0.59 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.59 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.59 |
| ▸ | HTR7 | P34969 | 1/20 | 0.59 |
| ▸ | DRD3 | P35462 | 1/20 | 0.59 |
| ▸ | HTR5A | P47898 | 1/20 | 0.59 |
| ▸ | HTR6 | P50406 | 1/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29557008 | 0.85 | HTR2A (1.00) | HTR2AHTR2CHTR2BHTR1ADRD1 | |
| SCHEMBL12352648 | 0.85 | HTR2A (1.00) | HTR2AHTR2CHTR2BHTR1ADRD1 | |
| SCHEMBL29992340 | 0.84 | HTR2A (0.76) | HTR2AHTR2CHTR2BHTR1ADRD1 | |
| SCHEMBL25030287 | 0.84 | HTR2A (0.76) | HTR2AHTR2CHTR2BHTR1ADRD1 | |
| SCHEMBL25008686 | 0.83 | HTR2A (0.70) | HTR2AHTR2CHTR2BHTR1ADRD1 | |
| SCHEMBL25008879 | 0.80 | HTR2A (0.74) | HTR2AHTR2CHTR2BHTR1ADRD1 | |
| SCHEMBL31027230 | 0.80 | HTR2A (0.74) | HTR2AHTR2CHTR2BHTR1ADRD1 | |
| SCHEMBL31614648 | 0.80 | HTR2A (0.74) | HTR2AHTR2CHTR2BHTR1ADRD1 | |
| SCHEMBL31027229 | 0.80 | HTR2A (0.74) | HTR2AHTR2CHTR2BHTR1ADRD1 | |
| SCHEMBL29168426 | 0.80 | HTR2A (0.74) | HTR2AHTR2CHTR2BHTR1ADRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230043896-A1 | HYDROXYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | MAGICMED INDUSTRIES INC. (CA) | 2023-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230043896-A1 | HYDROXYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | HTR1B, HTR2B, CYP8B1 | HTR2A 24/4885HTR2C 6/4885HTR2B 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.